Researchers led by Jeffrey L. Zink at UCLA have developed a method for encapsulating antimicrobial nanoparticles inside of mesoporous silica particles in service of creating a solid routine for the targeted delivery of nanoparticles, specifically for antimicrobial and bactericidal applications.
Studies involving bactericides have recently been focused on aiding the delivery of this material to specific beneficial sites. The desired outcome opportunities include incorporating antimicrobial materials into bandages for wound treatment and into water purification membranes. The innovation was possible because the mesoporous silica shell protects antimicrobial nanoparticles from aggregation and fast dissolution.
Other advantages include wider compatibility in biological environments, inexpensive, safe synthesis, and the ability to be incorporated into a variety of fabrics and substrates. The process was patented by Zink in 2012 and published by the UCLA Office of Intellectual Property & Industry Sponsored Research.
The original article can be found at UCLA’s Techtransfer.